Therefore, the comparative analysis of the JAK2V617F allele status of HSPCs subsets and sorted populations of PAR1±CD34±in MPN samples is crucial to gain insight into the hierarchy of PAR1 involvement in JAK2V617F activation across the cellular pool and within specific subsets. The gene discussed is F2R; the disease is myeloproliferative neoplasm.